These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34994965)

  • 61. A model to measure self-assessed proficiency in electronic medical records: Validation using maturity survey data from Canadian community-based physicians.
    Chong J; Jason T; Jones M; Larsen D
    Int J Med Inform; 2020 Sep; 141():104218. PubMed ID: 32574925
    [TBL] [Abstract][Full Text] [Related]  

  • 62. What is accountability in health care?
    Emanuel EJ; Emanuel LL
    Ann Intern Med; 1996 Jan; 124(2):229-39. PubMed ID: 8533999
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators.
    Martirosyan L; Markhorst J; Denig P; Haaijer-Ruskamp FM; Braspenning J
    BMC Health Serv Res; 2012 Jul; 12():191. PubMed ID: 22769967
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Faculty development initiatives designed to promote leadership in medical education. A BEME systematic review: BEME Guide No. 19.
    Steinert Y; Naismith L; Mann K
    Med Teach; 2012; 34(6):483-503. PubMed ID: 22578043
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation.
    Nissanholtz-Gannot R; Yankellevich A
    Isr J Health Policy Res; 2017 Sep; 6(1):45. PubMed ID: 28946915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.
    Olyaaeemanesh A; Jaafaripooyan E; Abdollahiasl A; Davari M; Mousavi SM; Delpasand M
    Health Res Policy Syst; 2021 Dec; 19(1):150. PubMed ID: 34949207
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance.
    Vian T; Kohler JC; Forte G; Dimancesco D
    J Pharm Policy Pract; 2017; 10():18. PubMed ID: 28588896
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patient safety and the ageing physician: a qualitative study of key stakeholder attitudes and experiences.
    White AA; Sage WM; Osinska PH; Salgaonkar MJ; Gallagher TH
    BMJ Qual Saf; 2019 Jun; 28(6):468-475. PubMed ID: 30237318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A modified Delphi process to identify process of care indicators for the identification, prevention and management of acute kidney injury after major surgery.
    James MT; Pannu N; Barry R; Karsanji D; Tonelli M; Hemmelgarn BR; Manns BJ; Bagshaw SM; Stelfox HT; Dixon E
    Can J Kidney Health Dis; 2015; 2():11. PubMed ID: 26060575
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2014; (42):31-62. PubMed ID: 25816561
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.
    Ashar BH; Miller RG; Getz KJ; Powe NR
    J Gen Intern Med; 2004 Nov; 19(11):1140-5. PubMed ID: 15566444
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The PMA Scale: A Measure of Physicians' Motivation to Adopt Medical Devices.
    Hatz MH; Sonnenschein T; Blankart CR
    Value Health; 2017 Apr; 20(4):533-541. PubMed ID: 28407994
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An international Delphi study examining health promotion and health education in nursing practice, education and policy.
    Whitehead D
    J Clin Nurs; 2008 Apr; 17(7):891-900. PubMed ID: 18321288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies.
    López-Toro AA; Sánchez-Teba EM; Benítez-Márquez MD; Rodríguez-Fernández M
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33923122
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Validation of a survey instrument to evaluate students' learning during community-based advanced pharmacy practice experiences.
    Kassam R; Collins JB
    Am J Pharm Educ; 2009 Oct; 73(6):106. PubMed ID: 19885075
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development and content validation of an instrument to support pharmaceutical counselling for dispensing of prescribed medicines.
    Rocha KSS; Cerqueira Santos S; Boaventura TC; Dos Santos Júnior GA; de Araújo DCSA; Silvestre CC; de Jesus EMS; de Lyra Júnior DP
    J Eval Clin Pract; 2020 Feb; 26(1):134-141. PubMed ID: 30701631
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sickness certification as a complex professional and collaborative activity--a qualitative study.
    Kiessling A; Arrelöv B
    BMC Public Health; 2012 Aug; 12():702. PubMed ID: 22928773
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Food Supply Chain Stakeholders' Perspectives on Sharing Information to Detect and Prevent Food Integrity Issues.
    Minnens F; Lucas Luijckx N; Verbeke W
    Foods; 2019 Jun; 8(6):. PubMed ID: 31242589
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Journey from an Enabler to a Strategic Leader: Integration of the Medical Affairs Function in ESG Initiatives and Values.
    Furtner D; Hutas G; Tan BJW; Meier R
    Pharmaceut Med; 2023 Nov; 37(6):405-416. PubMed ID: 37464231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.